SITE SEARCH 
Home About ISAPP News Meetings and Events ISAPP Activities and Publications Membership Intro to Probiotics and Prebiotics ISAPP Board of Directors Publications by ISAPP Board Industry Advisory Committee Links Contact Us
ISAPP's Position

Statement on

Probiotic Definition
ISAPP's Consumer

Guidelines for Choosing

a Probiotic or a

Prebiotic Product
 
ISAPP 2009. The 7th ISAPP meeting will be held November 3-5, 2009. This is a by-invitation-only meeting. It will be held in conjunction with the US National Academy of Sciences Sackler Symposium on "Microbes and Health" (November 1-3). Registration.
LATEST NEWS
5.26.2009
ISAPP Board of Directors member, Dr. Todd Klaenhammer, received the University of North Carolina Board of Governors’ highest faculty honor on May 8. The Board of Governors of the multi-campus University of North Carolina honored Dr. Klaenhammer with the O. Max Gardner Award, which since 1949 honors faculty who have "made the greatest contributions to the welfare of the human race." Press release. 10-min video/podcast.
5.25.2009
ISAPP’s president, Dr. Gregor Reid, named as inaugural chair in Human Microbiology and Probiotics at Lawson Health Research Institute, made possible by a $7 million investment by Danone Research. Press release.
5.20.2009
Health Canada prepares monograph on probiotics as a guide to industry for natural health product market authorization of probiotic products. Download monograph.
5.6.2009
Systematic review of probiotic safety commissioned by several US agencies. The Food and Drug Administration (FDA), the Office of Dietary Supplements (ODS), and the National Center for Complementary and Alternative Medicine (NCCAM) are co-sponsoring a systematic review of probiotic safety which will be led by Prof. Dr. Paul Shekelle, Director of the Southern California Evidence-based Practice Center and managed by the RAND Corporation. The review will encompass diverse probiotic genera used as probiotics (Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Enterococcus, and Bacillus) and is intended to provide tools for use by practitioners, researchers, and regulators to assess the value of and safety of probiotic administration to reduce risk, or prevent or treat disease, as well as to identify priorities or needs for future research.
4.30.2009
Norwegian Food Safety Authority recommends against use of probiotics in critically ill patients. Download opinion.
4.28.2009
ISAPP President, Gregor Reid, on "Research on Probiotics: A Well of Untapped Resources in Russia," published in International Science and Technology Center newsletter.
4.27.2009
Health Canada Food Directorate issues "Guidance Document - The Use of Probiotic Microorganisms in Food" along with along with a "Notice to Stakeholders." Referring to foods containing probiotics, these documents indicate that Health Canada will allow certain generic claims that do not require strain- or product-specific substantiation.


Probiotics are live microorganisms which when administered in adequate amount confer a health benefit on the host (FAO 2001).

Prebiotics are non-digestible (by the host) food ingredients that have a beneficial effect through their selective metabolism in the intestinal tract. (Gibson, G.R., Probert, H.M., van Loo, J.A.E., Rastall, R.A. and Roberfroid, M.B. 2004. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutrition Research Reviews 17, 259-275).

Our Mission

To engender and disseminate information on high quality, multidisciplinary, scientific investigation in the fields of probiotics and prebiotics, and to advance the development of scientifically substantiated, health-promoting probiotic and prebiotic products worldwide.


.
Photos courtesy of Prof. Lorenzo Morelli, Instituto di Microbiologia, Piacenza, Italy
All Content © Copyright 2007–2009 ISAPP. All Rights Reserved.